The use of cardiac hormones for assessing the risk of...

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/48 (2006.01) A61K 45/00 (2006.01) G01N 33/53 (2006.01) G01N 33/74 (2006.01)

Patent

CA 2500886

The present invention relates to the use of cardiac hormones, particularly natriuretic peptides, for assessment of risk of suffering from a cardiovascular complication, particularly heart disease or acute coronary syndrome, as a consequence of intravasal volume overload. In particular, the invention relates to a method for diagnosing the risk of a patient whose intravasal volume is increased or will be increased of suffering from a cardiovascular complication as a consequence of the increase of intravasal volume, comprising the steps of (a) taking a body fluid or tissue sample, and (b) measuring, preferably in vitro, the level of a cardiac hormone. The most preferred cardiac hormone in the context of the present invention is NT-proBNP.

La présente invention concerne l'utilisation d'hormones cardiaques, particulièrement de peptides natriurétiques, pour l'évaluation du risque de complication cardiovasculaire, particulièrement de cardiopathie ou de syndrome coronarien aigu, découlant d'un surplus de volume intravasal. Plus particulièrement, l'invention concerne une méthode pour diagnostiquer le risque qu'a un patient dont le volume intravasal a augmenté ou augmentera de présenter une complication cardiovasculaire découlant de l'augmentation du volume intravasal, laquelle comprend les étapes suivantes : a) prélèvement d'un échantillon de liquide organique ou de tissu; et b) mesure, de préférence in vitro, de la concentration d'une hormone cardiaque. L'hormone cardiaque de choix dans le contexte de la présente invention est NT-proBNP.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

The use of cardiac hormones for assessing the risk of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with The use of cardiac hormones for assessing the risk of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The use of cardiac hormones for assessing the risk of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1587963

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.